These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 27509054)

  • 1. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
    Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
    Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRP6 is identified as a potential prognostic marker for oral squamous cell carcinoma via MALDI-IMS.
    Yuan Y; Xie X; Jiang Y; Wei Z; Wang P; Chen F; Li X; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Wang Z; Chen Q
    Cell Death Dis; 2017 Sep; 8(9):e3035. PubMed ID: 28880263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of α-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis.
    Bag S; Dutta D; Chaudhary A; Sing BC; Pal M; Ray AK; Banerjee R; Paul RR; Basak A; Das AK; Chatterjee J
    J Clin Pathol; 2018 Mar; 71(3):228-238. PubMed ID: 28821582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
    Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
    Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
    Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
    Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
    Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
    Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
    PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
    Varun BR; Ranganathan K; Rao UK; Joshua E
    J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomic analysis for novel biomarkers of buccal squamous cell carcinoma arising in background of oral submucous fibrosis.
    Liu W; Zeng L; Li N; Wang F; Jiang C; Guo F; Chen X; Su T; Xu C; Zhang S; Fang C
    BMC Cancer; 2016 Aug; 16():584. PubMed ID: 27485544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis.
    Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L
    Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of CK8 and CK18 in leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma: an immunohistochemistry study.
    Nanda KD; Ranganathan K; Devi U; Joshua E
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):245-53. PubMed ID: 22677743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of PTPRZ1 in oral squamous cell carcinoma originated from oral submucous fibrosis and its clinical significance].
    Zhu R; Jian XC; Liu DY; Zhou C; Wang Y
    Shanghai Kou Qiang Yi Xue; 2017 Apr; 26(2):198-203. PubMed ID: 28815252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis.
    Yuan Y; Hou X; Feng H; Liu R; Xu H; Gong W; Deng J; Sun C; Gao Y; Peng J; Wu Y; Li J; Fang C; Chen Q
    Oncotarget; 2016 Sep; 7(37):60348-60365. PubMed ID: 27533088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A retrospective study of oral squamous cell carcinomas originated from oral submucous fibrosis].
    Guo F; Jian XC; Zhou SH; Li N; Hu YJ; Tang ZG
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Aug; 46(8):494-7. PubMed ID: 22169748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
    Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
    J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
    Routray S; Kheur SM; Kheur M
    Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.
    Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Wei KJ; Li J; Chen WT; Zhang ZY
    J Oral Pathol Med; 2009 Apr; 38(4):362-70. PubMed ID: 18673418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment.
    Zhi Y; Wang Q; Zi M; Zhang S; Ge J; Liu K; Lu L; Fan C; Yan Q; Shi L; Chen P; Fan S; Liao Q; Guo C; Wang F; Gong Z; Xiong W; Zeng Z
    Adv Sci (Weinh); 2024 Mar; 11(12):e2306515. PubMed ID: 38229179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skewed Th17/Treg balance during progression and malignant transformation of oral submucous fibrosis.
    Liu S; Liu Z; Shan Z; Liu Y; Chen T; Fang L; Quan H
    Oral Dis; 2022 Nov; 28(8):2119-2130. PubMed ID: 33749974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.